(Q34448772)

2 August 2017

title

A survey of the dose of ACE inhibitors prescribed by general physicians for patients with heart failure (English)

1 reference

2 August 2017

1 reference

McMullan R

1

1 reference

2 August 2017

Silke B

series ordinal

2

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

Postgraduate Medical Journal

2 August 2017

published in

1 reference

2 August 2017

volume

77

1 reference

2 August 2017

issue

914

1 reference

2 August 2017

page(s)

765-768

1 reference

ACE inhibitors and heart failure in hospital: any difference between cardiologists and general physicians?

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Differences in generalist and specialist physicians' knowledge and use of angiotensin-converting enzyme inhibitors for congestive heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Optimal dosage of ACE inhibitors in older patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Hormonal and renal differences between low dose and high dose angiotensin converting enzyme inhibitor treatment in patients with chronic heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

High or low dose of angiotensin-converting enzyme inhibitor in patients with left ventricular dysfunction?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Dose-response relationships of ACE inhibitors and angiotensin II blockers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

The use of angiotensin converting enzyme inhibitors in general practice--appropriate or inappropriate?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Factors determining angiotensin-converting enzyme inhibitor underutilization in heart failure in a community setting.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1742212

Do angiotensin-converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice?

27 October 2018

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition after myocardial infarction: the Trandolapril Cardiac Evaluation Study

1 reference

12 December 2020

Target doses of ACE inhibitors in heart failure: where should we aim?

1 reference

12 December 2020

Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure

1 reference

12 December 2020

Impact of angiotensin-converting enzyme inhibitor underdosing on rehospitalization rates in congestive heart failure

1 reference

12 December 2020

Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison

1 reference

12 December 2020

Determinants of angiotensin-converting enzyme inhibitor prescription in severe heart failure with left ventricular systolic dysfunction: the EPICAL study

1 reference

12 December 2020

Differences in drug treatment of chronic heart failure between European countries

1 reference

12 December 2020

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

12 December 2020

Identifiers

DOI

10.1136/PMJ.77.914.765

1 reference

2 August 2017

1 reference

2 August 2017

1 reference